| Prev Close | 19.65 |
| Day Low/High | 18.29 / 19.67 |
| 52 Wk Low/High | 17.29 / 36.48 |
MacroGenics, Inc. (MGNX)
18.77
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 61.26B |
| Market Cap | 1.20B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
February Trade Ideas Rundown: How'd We Do?
A fresh look at all 17 ideas: the winners, the losers and the still to be determined.
Play MacroGenics for a Potential Pop
I don't think MGNX has quite the same upside as IFRX, but a push above $23.50 should spur buying.
MacroGenics Soars on Collaboration with Incyte -- Biotech Movers
MacroGenics and Incyte on Wednesday unveiled a collaboration and license agreement regarding MGA012, MacroGenics' investigational monoclonal antibody that inhibits programmed cell death protein 1.
